Current Clinical Trials
Saturn
Study – AstraZeneca – Phase IIIb study
comparing effects of tx with rosuvastatin 40 mg or atorvastatin 80
mg on atherosclerotic disease burden as measured by IVUS in pts.
with CAD.
Current/Promote Automaticity IDE Study
– St. Jude Medical – A prospective,
non-randomized multi-center trial that will be conducted to assess
the safety and efficacy of the Promote CRT-D models and Current RF
ICD models or other St. Jude Medical ICD/CRT-D system with similar
functionality.
ARYx 505 – ARYx Therapeutics – A fib study
which is follow-up to the current study which compares Warfarin with
study drug. Treatment period is 12 months.
Freedom Study – SJM
- Evaluate the benefits of frequent AV/PV and V-V delay
optimization using Quick Opt in patients with CRT-D devices.
PREDICT Study –
CardioDX –The purpose of this study is to identify a gene
expression signature in peripheral blood cells that closely
correlates with the presence of clinically significant coronary
artery disease as determined by invasive X-ray coronary angiography
and/or multi-slice computed tomography coronary angiograph.
Triumph I Study –
Lung Rx – Efficacy and tolerability of inhaled treprostinil
sodium in patients with severe pulmonary arterial hypertension.
The National Institutes of Health provides a
thorough explanation of how clinical trials are conducted and
classified. Details for research participants are discussed at
http://clinicaltrials.gov/